Related Experiment Video

Updated: Dec 2, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

395

Management of Oligometastatic Prostate Cancer

James R Broughman1, Christopher W Fleming1, Omar Y Mian1

  • 1Dr. Broughman is a PGY4 chief resident, Dr. Fleming is a PGY5 resident, and Dr. Stephans, Dr. Mian, and Dr. Tendulkar are associate staff, all in the Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, OH.

Applied Radiation Oncology
|November 2, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.5K

Related Concept Videos